The EU retail investment package aims to strengthen the legislative framework to ensure that retail investors are empowered to take more informed investment decisions that better correspond to their needs and objectives, and are adequately protected in the single market by a coherent regulatory framework.
The Commission is proposing an ambitious revision of the EU pharmaceutical legislation (including a Directive and a Regulation), in order to, inter alia, create a Single Market for medicines, ensure an innovation-friendly framework for research and production and reduce the administrative burden.
The opinion will provide few but meaningful and concrete recommendations, reflecting the contributions made in the sections' and CCMI own-initiative opinions addressing the Blue Deal from their respective perspectives.
Download — EESK:s yttrande: Umbrella Opinion "A call for an EU Blue Deal"
The EESC welcomes the simpler and more transparent economic governance framework, the reduction of the pro-cyclical bias, the improvement in national ownership and strengthened enforcement, the differentiation and more tailored fiscal adjustment path of each Member State, based on a common-risk framework. However, the Committee proposes replacing the requirement obliging any Member State with a budget deficit of over 3% to cut that deficit by an average of 0.5% of GDP annually, and emphasises that the "technical trajectory" should be first in the hands of national governments and, at a second stage, be the result of a technical dialogue with the European Commission In due course. In due time, but by 2026 at the latest, an EU fiscal capacity should be established to meet at least some of the investment needs for common priorities and to allow Member States the fiscal space to meet the fiscal costs of the multiple transitions.
Download — EESK:s yttrande: New economic governance rules fit for the future
